FI952018A - Användning av BHAP-föreningar i kombination med andra icke-nukeocid-transverstransskriptasinhibitorer för behandling av HIV-infektion - Google Patents

Användning av BHAP-föreningar i kombination med andra icke-nukeocid-transverstransskriptasinhibitorer för behandling av HIV-infektion Download PDF

Info

Publication number
FI952018A
FI952018A FI952018A FI952018A FI952018A FI 952018 A FI952018 A FI 952018A FI 952018 A FI952018 A FI 952018A FI 952018 A FI952018 A FI 952018A FI 952018 A FI952018 A FI 952018A
Authority
FI
Finland
Prior art keywords
bhap
treatment
combination
reverse transcriptase
hiv infection
Prior art date
Application number
FI952018A
Other languages
English (en)
Finnish (fi)
Other versions
FI952018A0 (sv
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman M D Matts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI952018A publication Critical patent/FI952018A/sv
Publication of FI952018A0 publication Critical patent/FI952018A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI952018A 1992-10-28 1995-04-27 Användning av BHAP-föreningar i kombination med andra icke-nukeocid-transverstransskriptasinhibitorer för behandling av HIV-infektion FI952018A0 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12
PCT/US1993/008354 WO1994009781A1 (en) 1992-10-28 1993-09-10 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection

Publications (2)

Publication Number Publication Date
FI952018A true FI952018A (sv) 1995-04-27
FI952018A0 FI952018A0 (sv) 1995-04-27

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952018A FI952018A0 (sv) 1992-10-28 1995-04-27 Användning av BHAP-föreningar i kombination med andra icke-nukeocid-transverstransskriptasinhibitorer för behandling av HIV-infektion

Country Status (12)

Country Link
EP (1) EP0666744A1 (sv)
JP (1) JPH08502745A (sv)
KR (1) KR950703958A (sv)
AU (1) AU4848293A (sv)
CA (1) CA2145545A1 (sv)
CZ (1) CZ69695A3 (sv)
FI (1) FI952018A0 (sv)
HU (1) HUT72050A (sv)
MX (1) MX9306031A (sv)
NO (1) NO951608L (sv)
PL (1) PL308551A1 (sv)
WO (1) WO1994009781A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
KR20050033662A (ko) 2002-09-06 2005-04-12 얀센 파마슈티카 엔.브이. 헤테로사이클릭 화합물
WO2011123678A2 (en) 2010-03-31 2011-10-06 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
TW201307347A (zh) 2010-11-01 2013-02-16 Arqule Inc 經取代苯並－咪唑並－吡啶並－二氮呯化合物

Also Published As

Publication number Publication date
CA2145545A1 (en) 1994-05-11
MX9306031A (es) 1994-04-29
KR950703958A (ko) 1995-11-17
AU4848293A (en) 1994-05-24
NO951608L (no) 1995-06-28
EP0666744A1 (en) 1995-08-16
CZ69695A3 (en) 1995-12-13
JPH08502745A (ja) 1996-03-26
FI952018A0 (sv) 1995-04-27
HU9501218D0 (en) 1995-06-28
WO1994009781A1 (en) 1994-05-11
PL308551A1 (en) 1995-08-21
HUT72050A (en) 1996-03-28
NO951608D0 (no) 1995-04-27

Similar Documents

Publication Publication Date Title
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
DK0574457T3 (da) Antiviral nucleosidkombination
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
FI953954A (sv) Inhibitorer av HIV omvänd transkriptas
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
DK261490D0 (da) New pharmaceutical compound
BR9807523A (pt) Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids.
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
NO871883L (no) Fremgangsmaate for rensing av enkelt- og dobbeltkjedet vevplasminogenaktivator.
FI945199A0 (sv) Nya kinazoliner som inhibitorer för HIV omvänt transkriptas
FI952018A0 (sv) Användning av BHAP-föreningar i kombination med andra icke-nukeocid-transverstransskriptasinhibitorer för behandling av HIV-infektion
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
ATE243519T1 (de) Kombinationstherapie der hiv-infektion unter verwendung des hiv-protease inhibitors indinavir und des inhibitors der reversen transkriptase 3 tc zusammen mit azt.
NO913774D0 (no) Cykloheksylfenylpyrimidiner, fremgangsmaate for fremstilling og anvendelse i flytende krystallinske blandinger.
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DK514886A (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner og tautomere deraf, deresfremstilling og anvendelse som antidepressive midler
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DE3886155T2 (de) Anthracyclin-Derivate mit Inhibitorwirkung gegen die reverse Transkriptase des menschlichen Immundefizienzvirus.
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
FI941707A (sv) Användning av naftokinoner vid behandling och profylax av P. carinii -infektioner
SE9403861D0 (sv) Novel medicinal use
ES1014745Y (es) Instrumento quirurgico utilizado en el cierre de laparotomias.
FR2697532B1 (fr) Utilisation de compositions silicones pour le traitement de joints plats, notamment de joints de culasse.